Brief Behavioural Treatment for Insomnia in Dementia Carers
Launched by NHS GREATER GLASGOW AND CLYDE · Dec 2, 2016
Trial Information
Current as of May 17, 2025
Unknown status
Keywords
ClinConnect Summary
This study will explore the feasibility of delivering adapted BBTI in a group setting to family carers of people with dementia. The study will be a feasibility study given that delivering BBTI to groups of dementia carers hasn't been done before. It is therefore necessary to explore, in essence, whether it is 'do-able'. In-line with this, the current study will be considering the following:
* How many eligible participants consent to participate in the study?
* How many carers stay in the study until the end?
* Do carers find BBTI an acceptable treatment, are they able to comply with treat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Carer of person with dementia
- • Live with person being cared for
- • Meet Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for insomnia disorder with the exception that carers not meeting the frequency criterion of 3 times per week or duration criterion of 3 months will still be included if frequency is at least twice per week and duration 2 months.
- • competent in English language and have good basic literacy skills.
- Exclusion Criteria:
- • unstable, moderate to severe mental health issues (particularly Major Depressive Disorder and Bipolar Disorder)
- • already receiving a psychological intervention
- • untreated sleep disorders eg obstructive sleep apnoea, restless legs syndrome and periodic limb movement disorders.
- • current serious medical condition, such as cancer or recent remission from cancer
- • learning disability or a neurological condition (e.g. Multiple Sclerosis, Parkinson's disease, epilepsy)
- • being investigated for or existing diagnosis of degenerative condition
- • sleep problem primarily due to having to be awake during the night/early morning to respond to the needs of the person they care for
About Nhs Greater Glasgow And Clyde
NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glasgow, , United Kingdom
Patients applied
Trial Officials
Maria Gardani, PhD
Principal Investigator
University of Glasgow
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials